Nicotine Dependence
📧 Sign up to get email alerts when something new happens for Nicotine Dependence.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-10-01FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Oryza pharmaceuticals Inc.)
FDA approved a supplemental application for BUPROPION HYDROCHLORIDE XL from Oryza Pharmaceuticals Inc., indicating regulatory clearance of t…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: NeuroControl of Nicotine Dependence [NA]
Clinical trial update for a study on neurocontrol approaches to nicotine dependence, sponsored by the University of Missouri-Columbia, curre…
-
CLINICAL_TRIALS trial_result · 2024-09-27Clinical Trial Update: A Study to Evaluate Changes in Smokers Using An Oral Tobacco-Derived Nicotine Product [NA]
This update reports the completion of a study evaluating changes in smokers using an oral tobacco-derived nicotine product. Results were pos…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Proof-of-concept RCT of Version 3.0 of the Smoking Cessation Smartphone App "Smiling Instead of Smoking" (SiS) [NA]
This document reports results from a proof-of-concept randomized controlled trial evaluating version 3.0 of the Smiling Instead of Smoking (…
-
FDA approval · 2024-09-06FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Nicorette (nicotine polacrilex) submitted by Haleon US Holdings LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Effects of Menthol in E-cigarettes on Smoking Behaviors [Phase 1]
Phase 1 study evaluating whether menthol in electronic cigarettes influences smoking behaviors; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Self-activation in Individuals With and Without Nicotine Dependence [NA]
The clinical trial investigating self-activation in individuals with and without nicotine dependence was terminated, and results were posted…
-
FDA approval · 2024-08-26FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride from Sun Pharmaceutical Industries, Inc., confirming a generic version o…
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Nicotine's Potential Abuse With Menthol [EARLY_Phase 1]
Early-phase study investigating nicotine's potential abuse with menthol. Results were posted 2024-08-26.
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: Testing ANSOS for Efficacy in Multi-Tribal Urban Communities [NA]
Clinical trial update shows ANSOS is being studied for efficacy in smokeless tobacco cessation in multi-tribal urban communities. The study …
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace [Phase 3]
Phase 3 study evaluating the impact of very low nicotine content cigarettes in a complex marketplace; results have been posted.
-
CLINICAL_TRIALS research · 2024-08-19Clinical Trial Update: Mobile Phone-Based Smoking-Cessation Intervention for Chronic Patients [NA]
Beijing Normal University is sponsoring a clinical trial evaluating a mobile phone-based intervention to aid smoking cessation; the trial st…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Pharmacokinetics and Comparative Bioavailability of Nicotine From Two Variants of NP2, NP2-4mg and NP2-6mg, Compared to Nicotine Lozenge 4mg (Loz-4mg) and Nicotine Gum 4mg (Gum-4mg) [NA]
A completed pharmacokinetic study comparing nicotine absorption from two NP2 variants (NP2-4mg and NP2-6mg) with nicotine lozenge 4mg and ni…
-
CLINICAL_TRIALS trial_result · 2024-08-05Clinical Trial Update: Impact of Flavors on Nicotine Perception and Self-Administration Via E-cigarettes [Phase 2]
A Phase 2 clinical trial by Yale University evaluated how different e-liquid flavors affect nicotine perception and self-administration via …
-
CLINICAL_TRIALS withdrawal · 2024-08-02Clinical Trial Update: Video Messages for Smoking Cessation Campaign [NA]
A clinical trial update indicates that the NCT06284369 smoking cessation video messaging study sponsored by Loma Linda University has been w…
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Research and Innovation to Stop E-cigarette/Vaping in Young Adults [Phase 4]
Phase 4 trial completion and results posting for a study led by Ohio State University addressing nicotine dependence and e-cigarette use amo…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study [NA]
This is a trial update on a pilot study evaluating psilocybin-assisted therapy for smoking cessation in nicotine dependence; results have be…
-
FDA approval · 2024-07-23FDA Approved: VARENICLINE — Original Application (Nivagen Pharmaceuticals Inc.)
FDA approved the generic varenicline product from Nivagen Pharmaceuticals Inc. under an Original Application (ANDA 217115) for smoking cessa…
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: Abuse Liability and Appeal of Oral Nicotine Products [NA]
A USC-sponsored clinical trial (NCT06506162) is currently recruiting to evaluate abuse liability and appeal of oral nicotine products in ind…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Incentives for Oklahoma Tobacco Helpline Engagement in Persistent Poverty Counties [Phase 2]
This Phase 2 trial from the University of Oklahoma evaluated incentives to boost engagement with the Oklahoma Tobacco Helpline in persistent…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Evaluation of the Effectiveness of 5A-5R Counselling Services for Tobacco Cessation [NA]
This clinical trial update notes ongoing evaluation of 5A-5R counselling services for tobacco cessation sponsored by BRAC University, with e…
-
FDA approval · 2024-07-12FDA Approved: FOSTER AND THRIVE NICOTINE — Supplemental Application (Strategic Sourcing Services LLC)
The FDA approved a supplemental application for Foster and Thrive Nicotine (nicotine polacrylex) from Strategic Sourcing Services LLC, confi…
-
FDA approval · 2024-07-11FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Camber Pharmaceuticals’ generic Bupropion hydrochloride under an ANDA, authorizing a modificatio…
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: The Effect of an Anti-Smoking Mobile Application on Self-Efficacy, Decision Making and Breath Carbon Monoxide Levels [NA]
A clinical trial evaluating a mobile app intended to help smokers quit by boosting self-efficacy and decision making and by lowering breath …
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Short-Term Cardiovascular Effects of E-Cigarettes: Influence of Device Power [NA]
Completed clinical trial evaluating the short-term cardiovascular effects of electronic cigarettes and how device power modulates these resp…